Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Ahmad Mahamid | Surgery | Best Researcher Award

Assist. Prof. Dr. Ahmad Mahamid | Surgery | Best Researcher Award

Israel Institute of Technology, Carmel Medical Center, Haifa, Israel

Profile

Orcid

🧠 Early Academic Pursuits

Dr. Ahmad Mahamid began his distinguished academic journey at the Hebrew University in Jerusalem, where he earned a Bachelor of Medical Sciences (BMedSc, cum laude) in 2005, followed by an MD degree in 2010 from the Faculty of Medicine. These formative academic years laid a strong foundation for his future specialization in complex surgical disciplines, particularly within the fields of general surgery, surgical oncology, and hepatobiliary procedures.

🩺 Professional Endeavors

Following his medical degree, Dr. Mahamid embarked on a rigorous residency and fellowship pathway across top Israeli medical centers. From internship at Rabin Medical Center (2009–2010) to residencies in general surgery at Sourasky Medical Center and Hillel Yaffe Medical Center (2010–2016), he quickly demonstrated both technical expertise and leadership. His fellowship training spanned abdominal organ transplantation and HPB (hepato-pancreato-biliary) surgery, including a prestigious international fellowship at Mount Sinai Hospital in New York City (2019–2021), sharpening his expertise in complex oncologic and transplant surgery.

Currently, he serves as a Consultant in General and HPB Surgery across multiple health institutions including Mushlam Clalit, Meuhedet Health Services, and Ayalon Insurance Company Ltd. Since 2022, he has led the HPB Surgery Service at Carmel Medical Center, establishing it as a center of excellence for complex liver, pancreas, and biliary surgery in Israel.

🔬 Contributions and Research Focus

Dr. Mahamid’s research interests reflect his deep clinical experience and vision for innovation in surgery. His work focuses on abdominal organ transplantation, robotic HPB surgery, minimally invasive surgical techniques, and surgical oncology. He is also dedicated to advancing surgical imaging and diagnostics, with an added focus on trauma and emergency surgery. These areas form the basis of his contributions to developing safer, more precise, and patient-centric surgical practices.

🌍 Impact and Influence

Dr. Mahamid is highly active in Israel’s medical examination and professional certification systems. As a committee member and examiner for both the Israeli written and oral board exams in General Surgery, he plays a critical role in shaping future generations of surgeons. His involvement with the Israeli Society of Hepato-Pancreato-Biliary Surgery and International HPB Association underscores his leadership and commitment to advancing his field nationally and internationally. In 2023, he was appointed Secretary of the Israeli HPB Surgery Society, highlighting his influence within this highly specialized domain.

📚 Academic Appointments & Teaching Experience

A committed educator, Dr. Mahamid has taught and mentored students and residents extensively at the Technion – Israel Institute of Technology, where he has held positions ranging from tutor to director of various surgical training programs since 2011. His teaching spans pre-clinical medical school surgical rotations, TeAMS programs, and general surgery internships, as well as directing residency training at Carmel Medical Center. As of 2023, he holds the title of Clinical Senior Lecturer at the Technion’s Faculty of Medicine, reflecting his academic stature and commitment to surgical education.

🛠️ Technical & Clinical Skills

Dr. Mahamid is proficient in advanced surgical techniques, particularly within HPB and transplant surgery, including robotic-assisted and minimally invasive approaches. His international training and clinical exposure have equipped him with cutting-edge knowledge in surgical oncology, trauma care, and complex abdominal interventions. His expertise ensures that patients benefit from modern, safe, and effective surgical care.

🏅 Professional Leadership & Committee Roles

Between 2016 and the present, Dr. Mahamid has been deeply engaged in shaping Israel’s surgical standards. He has held multiple roles as an examiner and committee member for both residency exams and medical student assessments. In addition, he contributes to national-level discussions on surgical education and practice through his committee roles in the Israeli Surgical Association, Israeli Medical Association, and HPB societies. These responsibilities emphasize his stature as a respected voice in the surgical community.

📈 Legacy and Future Contributions

Dr. Ahmad Mahamid’s career is defined by a blend of clinical excellence, academic leadership, and educational mentorship. His work in advancing HPB surgery techniques, particularly in robotic and minimally invasive interventions, positions him at the forefront of surgical innovation in Israel. As he continues to lead surgical services, mentor the next generation of surgeons, and contribute to national medical governance, Dr. Mahamid is poised to leave a lasting legacy in both clinical practice and academic surgery.

📚 Selected Publications

Authors: Esther Kazlow, Elias Rinawi, Eden Gerszman, Samar Mattar, Nabih Essami, Mary Nasir, Aasem Abu Shtaya, Wisam Assaf, Riad Haddad, Ahmad Mahamid
Journal: Journal of Clinical Medicine
Year: 2025

Authors: Ahmad Mahamid, Eden Gerszman, Esther Kazlow, Aasem Abu Shtaya, Natalia Goldberg, Dvir Froylich, Riad Haddad
Journal: Cancers
Year: 2025

Authors: Ahmad Mahamid, Kobi Peleg, Alexander Givon, Rafi Alfici, Oran Olsha, Isaac Ashkenazi
Journal: American Journal of Emergency Medicine
Year: 2017

Authors: Ahmad Mahamid, Isaac Ashkenazi, Michal Shapira-Rootman, Oran Olsha, Rafi Alfici, Eyal Y. Bekhor, Isaac A. Mouch, Anwar R. Zeina
Journal: Journal of Gastrointestinal Cancer
Year: 2017

Author: Ahmad Mahamid
Journal: Harefuah
Year: 2017